Free Trial

Bunge Global (BG) Financials

Bunge Global logo
$126.22 -4.16 (-3.19%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$125.82 -0.41 (-0.32%)
As of 05/6/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Bunge Global

Annual Income Statements for Bunge Global

This table shows Bunge Global's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,610 2,243 1,137 816
Consolidated Net Income / (Loss)
1,678 2,337 1,188 843
Net Income / (Loss) Continuing Operations
1,678 2,337 1,188 846
Total Pre-Tax Income
2,066 3,051 1,524 1,134
Total Operating Income
2,313 3,130 1,617 1,296
Total Gross Profit
3,682 4,845 3,393 3,409
Total Revenue
67,232 59,540 53,108 70,329
Operating Revenue
67,232 59,540 53,108 70,329
Total Cost of Revenue
63,550 54,695 49,715 66,920
Operating Cost of Revenue
63,550 54,695 49,715 66,920
Total Operating Expenses
1,369 1,715 1,776 2,113
Selling, General & Admin Expense
1,369 1,715 1,776 2,113
Total Other Income / (Expense), net
-247 -79 -93 -162
Interest Expense
403 516 471 628
Interest & Investment Income
176 148 163 202
Other Income / (Expense), net
-20 289 215 264
Income Tax Expense
388 714 336 288
Net Income / (Loss) Discontinued Operations
- 0.00 0.00 -3.00
Net Income / (Loss) Attributable to Noncontrolling Interest
68 94 51 27
Basic Earnings per Share
$10.83 $15.07 $8.09 $4.95
Weighted Average Basic Shares Outstanding
- - 133.97M 193.51M
Diluted Earnings per Share
$10.51 $14.87 $7.99 $4.91
Weighted Average Diluted Shares Outstanding
- - 133.97M 193.51M
Weighted Average Basic & Diluted Shares Outstanding
- - 133.97M 193.51M
Cash Dividends to Common per Share
$2.30 $2.58 $2.70 $2.78

Quarterly Income Statements for Bunge Global

This table shows Bunge Global's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
622 373 244 70 221 602 201 354 166 95 68
Consolidated Net Income / (Loss)
629 389 252 73 233 630 204 370 181 88 75
Net Income / (Loss) Continuing Operations
629 389 252 73 233 630 204 370 184 88 75
Total Pre-Tax Income
827 503 369 103 322 730 284 494 270 86 61
Total Operating Income
945 598 437 215 335 630 217 320 385 374 235
Total Gross Profit
1,365 1,045 876 664 772 1,081 597 738 1,063 1,011 766
Total Revenue
15,049 14,227 13,417 13,241 12,908 13,542 11,643 12,769 22,155 23,762 21,861
Operating Revenue
15,049 14,227 13,417 13,241 12,908 13,542 11,643 12,769 22,155 23,762 21,861
Total Cost of Revenue
13,684 13,182 12,541 12,577 12,136 12,461 11,046 12,031 21,092 22,751 21,095
Operating Cost of Revenue
13,684 13,182 12,541 12,577 12,136 12,461 11,046 12,031 21,092 22,751 21,095
Total Operating Expenses
420 447 439 449 437 451 380 418 678 637 531
Selling, General & Admin Expense
420 447 439 449 437 451 380 418 678 637 531
Total Other Income / (Expense), net
-118 -95 -68 -112 -13 100 67 174 -115 -288 -174
Interest Expense
129 133 108 123 127 113 104 106 202 216 181
Interest & Investment Income
65 77 42 37 13 71 59 46 57 35 45
Other Income / (Expense), net
-54 -39 -2.00 -26 101 142 112 234 30 -107 -38
Income Tax Expense
198 114 117 30 89 100 80 124 86 -2.00 -14
Net Income / (Loss) Attributable to Noncontrolling Interest
7.00 16 8.00 3.00 12 28 3.00 16 15 -7.00 7.00
Basic Earnings per Share
$4.13 $2.50 $1.70 $0.49 $1.57 $4.33 $1.50 $2.63 $0.84 ($0.02) $0.35
Weighted Average Basic Shares Outstanding
- - - 141.65M 139.63M 133.97M 134.40M 200.06M 193.36M 193.51M 194.02M
Diluted Earnings per Share
$4.09 $2.47 $1.68 $0.48 $1.56 $4.27 $1.48 $2.61 $0.84 ($0.02) $0.35
Weighted Average Diluted Shares Outstanding
- - - 141.65M 139.63M 133.97M 134.40M 200.06M 193.36M 193.51M 194.02M
Weighted Average Basic & Diluted Shares Outstanding
- - - 141.65M 139.63M 133.97M 134.40M 200.06M 193.36M 193.51M 194.02M
Cash Dividends to Common per Share
$0.63 $0.66 $0.66 $0.68 $0.68 - $0.68 $0.70 $0.70 - $0.70

Annual Cash Flow Statements for Bunge Global

This table details how cash moves in and out of Bunge Global's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
247 1,471 705 -2,162
Net Cash From Operating Activities
-5,549 3,308 1,900 844
Net Cash From Continuing Operating Activities
-5,549 3,308 1,900 844
Net Income / (Loss) Continuing Operations
1,678 2,337 1,188 843
Consolidated Net Income / (Loss)
1,678 2,337 1,188 843
Depreciation Expense
408 451 468 703
Non-Cash Adjustments To Reconcile Net Income
-6,699 -779 679 221
Changes in Operating Assets and Liabilities, net
-936 1,299 -435 -923
Net Cash From Investing Activities
6,499 -1,009 -1,114 -5,227
Net Cash From Continuing Investing Activities
6,499 -1,009 -1,114 -5,227
Purchase of Property, Plant & Equipment
-555 -1,122 -1,376 -1,723
Acquisitions
- 0.00 0.00 -4,201
Purchase of Investments
-511 -269 -1,275 -3,152
Sale of Property, Plant & Equipment
508 170 8.00 953
Divestitures
0.00 0.00 728 100
Sale and/or Maturity of Investments
326 49 887 2,753
Other Investing Activities, net
6,731 163 -86 43
Net Cash From Financing Activities
-769 -856 -90 2,229
Net Cash From Continuing Financing Activities
-769 -856 -90 2,229
Repayment of Debt
-2,938 -2,105 -1,774 -2,677
Repurchase of Common Equity
-302 -600 -1,100 -569
Payment of Dividends
-349 -383 -378 -459
Issuance of Debt
2,180 2,255 3,109 5,698
Issuance of Common Equity
542 0.00 0.00 206
Other Financing Activities, net
98 -23 53 30
Effect of Exchange Rate Changes
- 28 9.00 -8.00

Quarterly Cash Flow Statements for Bunge Global

This table details how cash moves in and out of Bunge Global's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
430 330 -1,752 1,688 439 -79 3,563 -5,487 -159 -319
Net Cash From Operating Activities
1,448 994 -1,474 1,327 1,053 -285 -1,072 854 1,347 -541
Net Cash From Continuing Operating Activities
1,448 994 -1,474 1,327 1,053 -285 -1,072 854 1,347 -541
Net Income / (Loss) Continuing Operations
660 252 73 233 630 204 370 181 88 75
Consolidated Net Income / (Loss)
660 252 73 233 630 204 370 181 88 75
Depreciation Expense
134 112 114 119 123 120 116 241 226 238
Non-Cash Adjustments To Reconcile Net Income
2.00 283 277 151 -32 -197 -526 -263 1,207 687
Changes in Operating Assets and Liabilities, net
652 347 -1,938 824 332 -412 -1,032 695 -174 -1,541
Net Cash From Investing Activities
-363 -396 -152 -409 -157 -280 178 -5,422 297 -182
Net Cash From Continuing Investing Activities
-363 -396 -152 -409 -157 -280 178 -5,422 297 -182
Purchase of Property, Plant & Equipment
-317 -236 -297 -354 -489 -310 -406 -469 -538 -336
Acquisitions
- - - - - 0.00 - - -85 -105
Purchase of Investments
-50 -376 -281 -242 -376 -476 -397 -1,701 -578 -448
Divestitures
- 0.00 103 - 625 100 - - - 0.00
Sale and/or Maturity of Investments
28 239 315 185 148 339 511 387 1,516 681
Other Investing Activities, net
-29 -23 5.00 -1.00 -67 67 -2.00 3.00 -25 26
Net Cash From Financing Activities
-643 -259 -129 764 -466 490 4,448 -917 -1,792 406
Net Cash From Continuing Financing Activities
-643 -259 -129 764 -466 490 4,448 -917 -1,792 406
Repayment of Debt
-766 -32 -307 -1,121 -325 -110 2,042 -1,893 -2,716 -1,378
Payment of Dividends
-96 -95 -96 -96 -91 -109 -94 -139 -117 -136
Issuance of Debt
407 253 258 2,171 427 496 2,477 1,660 1,065 1,904
Issuance of Common Equity
- 0.00 - - - 206 - - - 0.00
Other Financing Activities, net
-54 15 16 10 23 7.00 23 - - 16
Effect of Exchange Rate Changes
- -9.00 3.00 6.00 - -4.00 9.00 -2.00 -11 -2.00

Annual Balance Sheets for Bunge Global

This table presents Bunge Global's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
25,372 24,899 44,528
Total Current Assets
16,350 15,958 24,391
Cash & Equivalents
2,602 3,311 1,135
Note & Lease Receivable
- - 208
Accounts Receivable
2,592 2,148 3,870
Inventories, net
7,105 6,491 13,198
Other Current Assets
4,051 4,000 5,789
Other Current Nonoperating Assets
- 8.00 191
Plant, Property, & Equipment, net
4,541 5,254 11,678
Total Noncurrent Assets
4,481 3,687 8,459
Long-Term Investments
1,280 779 1,495
Goodwill
489 453 3,141
Intangible Assets
398 321 309
Noncurrent Deferred & Refundable Income Taxes
773 645 890
Other Noncurrent Operating Assets
1,541 1,489 2,624
Total Liabilities & Shareholders' Equity
25,372 24,899 44,528
Total Liabilities
13,557 13,950 27,106
Total Current Liabilities
7,687 7,435 15,127
Short-Term Debt
1,110 1,544 5,220
Accounts Payable
3,664 2,777 4,881
Other Current Liabilities
2,913 3,104 4,965
Other Current Nonoperating Liabilities
- 10 61
Total Noncurrent Liabilities
5,870 6,515 11,979
Long-Term Debt
4,080 4,694 8,831
Noncurrent Deferred & Payable Income Tax Liabilities
400 379 988
Other Noncurrent Operating Liabilities
1,390 1,442 2,160
Redeemable Noncontrolling Interest
1.00 4.00 53
Total Equity & Noncontrolling Interests
11,814 10,945 17,369
Total Preferred & Common Equity
10,851 9,913 15,904
Total Common Equity
10,849 9,912 15,904
Common Stock
5,899 5,325 9,843
Retained Earnings
12,077 12,838 13,152
Treasury Stock
-1,073 -1,549 -1,007
Accumulated Other Comprehensive Income / (Loss)
-6,054 -6,702 -6,084
Noncontrolling Interest
963 1,032 1,465

Quarterly Balance Sheets for Bunge Global

This table presents Bunge Global's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 12/31/2023 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
25,372 24,428 25,267 24,899 26,660 31,154 46,298 47,576
Total Current Assets
16,350 15,452 15,919 15,958 17,373 21,445 26,719 27,094
Cash & Equivalents
2,602 1,161 2,836 3,311 3,245 6,790 1,315 839
Note & Lease Receivable
- - - - - - 546 102
Accounts Receivable
2,592 2,277 2,100 2,148 2,334 2,258 3,494 3,975
Inventories, net
7,105 8,057 7,465 6,491 7,817 8,014 13,312 15,428
Other Current Assets
4,051 3,957 3,518 4,008 3,800 4,205 7,858 6,554
Other Current Nonoperating Assets
- - - - 177 178 194 196
Plant, Property, & Equipment, net
4,541 4,751 5,115 5,254 5,511 5,828 11,550 11,877
Total Noncurrent Assets
4,481 4,225 4,233 3,687 3,776 3,881 8,029 8,605
Long-Term Investments
1,280 1,193 1,136 779 800 862 1,490 1,276
Goodwill
489 466 482 453 463 460 2,769 3,291
Intangible Assets
398 355 358 321 319 316 328 304
Noncurrent Deferred & Refundable Income Taxes
773 698 725 645 648 646 789 934
Other Noncurrent Operating Assets
1,541 1,513 1,532 1,489 1,546 1,597 2,653 2,800
Total Liabilities & Shareholders' Equity
25,372 24,428 25,267 24,899 26,660 31,154 46,298 47,576
Total Liabilities
13,557 13,443 14,109 13,950 15,067 19,198 29,007 30,099
Total Current Liabilities
7,687 7,606 7,691 7,435 8,535 10,384 16,097 16,940
Short-Term Debt
1,110 954 1,418 1,544 2,003 4,225 5,780 4,606
Accounts Payable
3,664 3,429 3,211 2,777 3,831 2,894 4,780 6,176
Other Current Liabilities
2,913 3,223 3,062 3,114 2,629 3,198 5,464 6,098
Other Current Nonoperating Liabilities
- - - - 72 67 73 60
Total Noncurrent Liabilities
5,870 5,837 6,418 6,515 6,532 8,814 12,910 13,159
Long-Term Debt
4,080 4,086 4,777 4,694 4,714 7,044 9,809 9,947
Noncurrent Deferred & Payable Income Tax Liabilities
400 369 376 379 373 347 925 929
Other Noncurrent Operating Liabilities
1,390 1,382 1,265 1,442 1,445 1,423 2,176 2,283
Redeemable Noncontrolling Interest
1.00 1.00 2.00 4.00 49 61 61 51
Total Equity & Noncontrolling Interests
11,814 10,984 11,156 10,945 11,544 11,895 17,230 17,426
Total Preferred & Common Equity
10,851 10,002 10,135 9,913 10,578 10,883 15,768 16,045
Total Common Equity
10,849 10,000 10,133 9,911 10,576 10,881 15,768 16,045
Common Stock
5,899 5,868 5,880 5,324 5,489 5,501 10,873 9,813
Retained Earnings
12,077 12,005 12,231 12,838 13,034 13,011 13,053 13,216
Treasury Stock
-1,073 -1,427 -1,624 -1,549 -1,511 -1,508 -2,051 -967
Accumulated Other Comprehensive Income / (Loss)
-6,054 -6,446 -6,354 -6,702 -6,436 -6,123 -6,107 -6,017
Noncontrolling Interest
963 982 1,021 1,032 966 1,012 1,462 1,381

Annual Metrics And Ratios for Bunge Global

This table displays calculated financial ratios and metrics derived from Bunge Global's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - -
Revenue Growth
0.00% -11.44% -10.80% 32.43%
EBITDA Growth
0.00% 43.28% -40.57% -1.61%
EBIT Growth
0.00% 49.11% -46.42% -14.85%
NOPAT Growth
0.00% 27.62% -47.42% -23.30%
Net Income Growth
0.00% 39.27% -49.17% -29.04%
EPS Growth
0.00% 41.48% -46.27% -38.55%
Operating Cash Flow Growth
0.00% 159.61% -42.56% -55.58%
Free Cash Flow Firm Growth
0.00% 0.00% 111.99% -1,240.30%
Invested Capital Growth
0.00% 0.00% -0.20% 119.20%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 17.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -15.08%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -24.46%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -20.20%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -39.13%
EPS Q/Q Growth
0.00% 0.00% 0.00% -46.63%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 53.45%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -4.14%
Profitability Metrics
- - - -
Gross Margin
5.48% 8.14% 6.39% 4.85%
EBITDA Margin
4.02% 6.50% 4.33% 3.22%
Operating Margin
3.44% 5.26% 3.04% 1.84%
EBIT Margin
3.41% 5.74% 3.45% 2.22%
Profit (Net Income) Margin
2.50% 3.93% 2.24% 1.20%
Tax Burden Percent
81.22% 76.60% 77.95% 74.34%
Interest Burden Percent
90.10% 89.24% 83.19% 72.69%
Effective Tax Rate
18.78% 23.40% 22.05% 25.40%
Return on Invested Capital (ROIC)
0.00% 36.54% 9.61% 4.62%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 27.29% 5.42% 2.78%
Return on Net Nonoperating Assets (RNNOA)
0.00% 3.02% 0.82% 1.32%
Return on Equity (ROE)
0.00% 39.56% 10.44% 5.94%
Cash Return on Invested Capital (CROIC)
0.00% -163.46% 9.81% -70.06%
Operating Return on Assets (OROA)
0.00% 13.48% 7.29% 4.49%
Return on Assets (ROA)
0.00% 9.21% 4.73% 2.43%
Return on Common Equity (ROCE)
0.00% 36.33% 9.52% 5.41%
Return on Equity Simple (ROE_SIMPLE)
0.00% 21.54% 11.98% 0.00%
Net Operating Profit after Tax (NOPAT)
1,879 2,398 1,260 967
NOPAT Margin
2.79% 4.03% 2.37% 1.37%
Net Nonoperating Expense Percent (NNEP)
0.00% 9.25% 4.20% 1.84%
Return On Investment Capital (ROIC_SIMPLE)
- 14.10% 7.34% 3.08%
Cost of Revenue to Revenue
94.52% 91.86% 93.61% 95.15%
SG&A Expenses to Revenue
2.04% 2.88% 3.34% 3.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
2.04% 2.88% 3.34% 3.00%
Earnings before Interest and Taxes (EBIT)
2,293 3,419 1,832 1,560
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,701 3,870 2,300 2,263
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.00 1.04 1.08
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.13 1.38
Price to Revenue (P/Rev)
0.00 0.00 0.19 0.24
Price to Earnings (P/E)
0.00 0.00 9.07 21.00
Dividend Yield
2.46% 2.65% 3.51% 3.14%
Earnings Yield
0.00% 0.00% 11.02% 4.76%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.03 1.05
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.25 0.43
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 5.87 13.29
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 7.37 19.28
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 10.71 31.11
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 7.11 35.64
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 10.49 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 0.44 0.57 0.81
Long-Term Debt to Equity
0.00 0.35 0.43 0.51
Financial Leverage
0.00 0.11 0.15 0.47
Leverage Ratio
0.00 2.15 2.21 2.45
Compound Leverage Factor
0.00 1.92 1.84 1.78
Debt to Total Capital
0.00% 30.52% 36.29% 44.64%
Short-Term Debt to Total Capital
0.00% 6.53% 8.98% 16.59%
Long-Term Debt to Total Capital
0.00% 23.99% 27.31% 28.06%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 5.67% 6.03% 4.82%
Common Equity to Total Capital
0.00% 63.80% 57.67% 50.53%
Debt to EBITDA
0.00 1.34 2.71 6.21
Net Debt to EBITDA
0.00 0.34 0.93 5.05
Long-Term Debt to EBITDA
0.00 1.05 2.04 3.90
Debt to NOPAT
0.00 2.16 4.95 14.53
Net Debt to NOPAT
0.00 0.55 1.70 11.81
Long-Term Debt to NOPAT
0.00 1.70 3.72 9.13
Altman Z-Score
0.00 0.00 3.95 2.74
Noncontrolling Interest Sharing Ratio
0.00% 8.18% 8.80% 9.01%
Liquidity Ratios
- - - -
Current Ratio
0.00 2.13 2.15 1.61
Quick Ratio
0.00 0.68 0.73 0.34
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -10,725 1,286 -14,647
Operating Cash Flow to CapEx
-11,806.38% 347.48% 138.89% 109.61%
Free Cash Flow to Firm to Interest Expense
0.00 -20.79 2.73 -23.32
Operating Cash Flow to Interest Expense
-13.77 6.41 4.03 1.34
Operating Cash Flow Less CapEx to Interest Expense
-13.89 4.57 1.13 0.12
Efficiency Ratios
- - - -
Asset Turnover
0.00 2.35 2.11 2.03
Accounts Receivable Turnover
0.00 22.97 22.41 23.37
Inventory Turnover
0.00 7.70 7.31 6.80
Fixed Asset Turnover
0.00 13.11 10.84 0.00
Accounts Payable Turnover
0.00 14.93 15.44 17.48
Days Sales Outstanding (DSO)
0.00 15.89 16.29 15.62
Days Inventory Outstanding (DIO)
0.00 47.41 49.91 53.69
Days Payable Outstanding (DPO)
0.00 24.45 23.64 20.88
Cash Conversion Cycle (CCC)
0.00 38.85 42.55 48.43
Capital & Investment Metrics
- - - -
Invested Capital
0.00 13,123 13,097 28,713
Invested Capital Turnover
0.00 9.07 4.05 3.36
Increase / (Decrease) in Invested Capital
0.00 13,123 -26 15,614
Enterprise Value (EV)
0.00 0.00 13,501 30,078
Market Capitalization
0.00 0.00 10,317 17,139
Book Value per Share
$0.00 $0.00 $70.98 $82.25
Tangible Book Value per Share
$0.00 $0.00 $65.44 $64.41
Total Capital
0.00 17,005 17,187 31,473
Total Debt
0.00 5,190 6,238 14,051
Total Long-Term Debt
0.00 4,080 4,694 8,831
Net Debt
0.00 1,308 2,148 11,421
Capital Expenditures (CapEx)
47 952 1,368 770
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 7,171 6,756 13,349
Debt-free Net Working Capital (DFNWC)
0.00 9,773 10,067 14,484
Net Working Capital (NWC)
0.00 8,663 8,523 9,264
Net Nonoperating Expense (NNE)
201 61 72 124
Net Nonoperating Obligations (NNO)
0.00 1,308 2,148 11,291
Total Depreciation and Amortization (D&A)
408 451 468 703
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 12.04% 12.72% 18.98%
Debt-free Net Working Capital to Revenue
0.00% 16.41% 18.96% 20.59%
Net Working Capital to Revenue
0.00% 14.55% 16.05% 13.17%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $8.09 $4.95
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 133.97M 193.51M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $7.99 $4.91
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 133.97M 193.51M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 133.97M 193.51M
Normalized Net Operating Profit after Tax (NOPAT)
1,879 2,398 1,260 967
Normalized NOPAT Margin
2.79% 4.03% 2.37% 1.37%
Pre Tax Income Margin
3.07% 5.12% 2.87% 1.61%
Debt Service Ratios
- - - -
EBIT to Interest Expense
5.69 6.63 3.89 2.48
NOPAT to Interest Expense
4.66 4.65 2.68 1.54
EBIT Less CapEx to Interest Expense
5.57 4.78 0.99 1.26
NOPAT Less CapEx to Interest Expense
4.54 2.80 -0.23 0.31
Payout Ratios
- - - -
Dividend Payout Ratio
20.80% 16.39% 31.82% 54.45%
Augmented Payout Ratio
38.80% 42.06% 124.41% 121.95%

Quarterly Metrics And Ratios for Bunge Global

This table displays calculated financial ratios and metrics derived from Bunge Global's official financial filings.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 193,509,080.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 193,509,080.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.35
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% -12.01% -9.27% 0.00% -13.22% -3.56% 71.64% 75.47% 87.76%
EBITDA Growth
0.00% 0.00% 0.00% -65.99% -25.58% 0.00% -18.83% 121.12% 18.20% -44.92% -3.12%
EBIT Growth
0.00% 0.00% 0.00% -78.79% -25.58% 0.00% -25.52% 193.12% -4.82% -65.41% -40.12%
NOPAT Growth
0.00% 0.00% 0.00% -78.80% -47.58% 0.00% -47.77% 57.29% 8.24% -29.61% 85.37%
Net Income Growth
0.00% 0.00% 0.00% -88.39% -40.10% 0.00% -19.05% 406.85% -22.32% -86.03% -63.24%
EPS Growth
0.00% 0.00% 0.00% -88.26% -36.84% 0.00% -11.90% 443.75% -46.15% -100.47% -76.35%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% 0.00% -27.28% -128.67% 27.27% -35.64% 27.92% -89.82%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 88.52% -24.14% 0.00% -9.47%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.10% 123.85% 119.20% 110.30%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -1.31% 0.00% 4.91% 0.00% 9.67% 73.51% 7.25% -8.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -44.61% 0.00% 61.26% 0.00% 50.90% -2.09% -24.85% -11.76%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -56.55% 0.00% 77.06% 0.00% 70.99% -25.09% -35.66% -26.22%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -48.94% 0.00% 124.29% 0.00% 53.76% 9.47% 45.86% -24.50%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -71.03% 0.00% 170.39% 0.00% 81.37% -51.08% -51.38% -14.77%
EPS Q/Q Growth
0.00% 0.00% 0.00% -71.43% 0.00% 173.72% 0.00% 76.35% -67.82% -102.38% 1,850.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -31.35% -248.29% 0.00% -20.65% -127.07% -276.14% 179.66% 57.73% -140.16%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 0.00% 88.92% -951.40% 6.62% -0.65%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -2.11% 0.00% 9.19% 93.73% -4.14% 3.71%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
9.07% 7.35% 6.53% 5.01% 5.98% 7.98% 5.13% 5.78% 4.80% 4.25% 3.50%
EBITDA Margin
5.92% 3.93% 4.08% 2.29% 3.22% 6.61% 3.81% 5.25% 2.96% 2.07% 1.99%
Operating Margin
6.28% 4.20% 3.26% 1.62% 2.60% 4.65% 1.86% 2.51% 1.74% 1.57% 1.08%
EBIT Margin
5.92% 3.93% 3.24% 1.43% 3.22% 5.70% 2.78% 4.34% 1.87% 1.12% 0.90%
Profit (Net Income) Margin
4.18% 2.73% 1.88% 0.55% 1.81% 4.65% 1.75% 2.90% 0.82% 0.37% 0.34%
Tax Burden Percent
76.06% 77.34% 68.29% 70.87% 72.36% 86.30% 71.83% 74.90% 67.04% 102.33% 122.95%
Interest Burden Percent
92.82% 89.98% 84.83% 54.50% 77.40% 94.56% 87.65% 89.17% 65.06% 32.21% 30.96%
Effective Tax Rate
23.94% 22.66% 31.71% 29.13% 27.64% 13.70% 28.17% 25.10% 31.85% -2.33% -22.95%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 16.28% 9.71% 6.55% 3.29% 5.42% 4.85%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 20.29% 13.46% 10.76% 2.19% 1.03% 1.97%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 3.98% 2.98% 2.91% 1.15% 0.49% 1.01%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 0.00% 20.26% 12.69% 9.46% 4.43% 5.91% 5.85%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 9.81% 0.00% 0.00% 0.00% -70.06% -66.39%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 12.05% 5.36% 7.94% 3.15% 2.28% 1.96%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 9.83% 3.37% 5.30% 1.37% 0.75% 0.74%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 0.00% 18.48% 11.57% 8.61% 4.04% 5.38% 5.36%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.78% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
719 462 298 152 242 544 156 240 262 383 289
NOPAT Margin
4.78% 3.25% 2.22% 1.15% 1.88% 4.01% 1.34% 1.88% 1.18% 1.61% 1.32%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 5.91% 0.85% -4.01% -3.75% -4.21% 1.09% 4.39% 2.88%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.95% 1.40% 3.16% 0.85% 1.03% 0.80% 1.22% 0.90%
Cost of Revenue to Revenue
90.93% 92.65% 93.47% 94.99% 94.02% 92.02% 94.87% 94.22% 95.20% 95.75% 96.50%
SG&A Expenses to Revenue
2.79% 3.14% 3.27% 3.39% 3.39% 3.33% 3.26% 3.27% 3.06% 2.68% 2.43%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
2.79% 3.14% 3.27% 3.39% 3.39% 3.33% 3.26% 3.27% 3.06% 2.68% 2.43%
Earnings before Interest and Taxes (EBIT)
891 559 435 189 416 772 324 554 415 267 197
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
891 559 547 303 416 895 444 670 656 493 435
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 1.46 1.32 1.01 0.97 1.48 1.00 1.08 1.54
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 1.59 1.44 1.10 1.05 1.59 1.24 1.38 1.98
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.19 0.20 0.32 0.26 0.24 0.31
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 8.80 9.39 11.66 11.88 21.00 36.13
Dividend Yield
2.79% 2.43% 2.63% 2.58% 2.80% 3.62% 3.56% 3.41% 3.40% 3.14% 2.20%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 11.36% 10.65% 8.58% 8.42% 4.76% 2.77%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.34 1.24 1.01 0.99 1.34 1.00 1.05 1.29
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.25 0.27 0.41 0.50 0.43 0.48
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 5.74 6.35 8.09 11.26 13.29 17.14
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 7.20 8.11 9.95 14.54 19.28 27.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 10.47 12.61 17.59 24.78 31.11 37.28
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 7.77 0.00 6.94 22.48 20.28 54.58 35.64 65.56
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.46 0.56 0.57 0.58 0.94 0.90 0.81 0.83
Long-Term Debt to Equity
0.00 0.00 0.00 0.37 0.43 0.43 0.41 0.59 0.57 0.51 0.57
Financial Leverage
0.00 0.00 0.00 0.24 0.20 0.20 0.22 0.27 0.52 0.47 0.51
Leverage Ratio
0.00 0.00 0.00 2.22 2.26 2.21 2.30 2.42 2.52 2.45 2.55
Compound Leverage Factor
0.00 0.00 0.00 1.21 1.75 2.09 2.02 2.16 1.64 0.79 0.79
Debt to Total Capital
0.00% 0.00% 0.00% 31.45% 35.70% 36.29% 36.68% 48.52% 47.41% 44.64% 45.44%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 5.95% 8.17% 8.98% 10.94% 18.19% 17.58% 16.59% 14.38%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 25.50% 27.53% 27.31% 25.75% 30.33% 29.83% 28.06% 31.06%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 6.13% 5.90% 6.03% 5.54% 4.62% 4.63% 4.82% 4.47%
Common Equity to Total Capital
0.00% 0.00% 0.00% 62.40% 58.39% 57.67% 57.76% 46.85% 47.96% 50.53% 50.09%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 2.71 3.06 4.40 5.85 6.21 6.47
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.93 1.22 1.41 4.80 5.05 5.53
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 2.04 2.15 2.75 3.68 3.90 4.42
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 4.95 6.07 9.55 12.87 14.53 14.07
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 1.70 2.41 3.07 10.55 11.81 12.03
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 3.72 4.26 5.97 8.10 9.13 9.62
Altman Z-Score
0.00 0.00 0.00 0.00 0.00 3.80 3.46 3.20 2.32 2.64 2.84
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 8.80% 8.77% 8.98% 8.96% 9.01% 8.42%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 0.00 0.00 2.03 2.07 2.15 2.04 2.07 1.66 1.61 1.60
Quick Ratio
0.00 0.00 0.00 0.45 0.64 0.73 0.65 0.87 0.33 0.34 0.29
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 -13,519 -13,139 0.00 -14,004 -1,551 -16,311 -15,231 -15,330
Operating Cash Flow to CapEx
0.00% 0.00% 421.19% -496.30% 0.00% 216.22% -91.94% -264.04% 0.00% 253.67% -161.01%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 -109.91 -103.45 0.00 -134.66 -14.64 -80.75 -70.52 -84.70
Operating Cash Flow to Interest Expense
0.00 0.00 9.20 -11.98 0.00 9.32 -2.74 -10.11 4.23 6.24 -2.99
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 7.02 -14.40 0.00 5.01 -5.72 -13.94 4.25 3.78 -4.85
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 2.11 1.93 1.83 1.68 2.03 2.17
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 22.41 21.99 22.43 21.49 23.37 25.53
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 7.31 6.17 5.93 5.45 6.80 6.62
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 10.84 9.31 9.62 7.21 0.00 9.26
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 15.44 12.59 15.08 14.17 17.48 15.38
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 16.29 16.60 16.27 16.98 15.62 14.29
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 49.91 59.17 61.52 66.96 53.69 55.12
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 23.64 29.00 24.21 25.75 20.88 23.73
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 42.55 46.77 53.59 58.19 48.43 45.68
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 0.00 0.00 13,671 13,381 13,099 14,160 15,462 29,954 28,713 29,779
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 4.05 7.25 3.49 2.77 3.36 3.67
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 13,671 13,381 0.00 14,160 1,791 16,573 15,614 15,619
Enterprise Value (EV)
0.00 0.00 0.00 18,303 16,638 13,192 13,958 20,751 30,018 30,078 38,549
Market Capitalization
0.00 0.00 0.00 14,634 13,392 10,008 10,271 16,061 15,711 17,139 24,679
Book Value per Share
$0.00 $0.00 $0.00 $70.60 $72.57 $70.99 $78.94 $80.96 $78.82 $82.25 $82.92
Tangible Book Value per Share
$0.00 $0.00 $0.00 $64.80 $66.56 $65.45 $73.11 $75.18 $63.34 $64.41 $64.34
Total Capital
0.00 0.00 0.00 16,025 17,353 17,187 18,310 23,225 32,880 31,473 32,030
Total Debt
0.00 0.00 0.00 5,040 6,195 6,238 6,717 11,269 15,589 14,051 14,553
Total Long-Term Debt
0.00 0.00 0.00 4,086 4,777 4,694 4,714 7,044 9,809 8,831 9,947
Net Debt
0.00 0.00 0.00 2,686 2,223 2,148 2,672 3,617 12,784 11,421 12,438
Capital Expenditures (CapEx)
0.00 0.00 236 297 0.00 487 310 406 -5.00 531 336
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 7,639 6,810 6,756 7,596 8,496 15,087 13,349 13,921
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 8,800 9,646 10,067 10,841 15,286 16,402 14,484 14,760
Net Working Capital (NWC)
0.00 0.00 0.00 7,846 8,228 8,523 8,838 11,061 10,622 9,264 10,154
Net Nonoperating Expense (NNE)
90 73 46 79 9.41 -86 -48 -130 81 295 214
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 2,686 2,223 2,150 2,567 3,506 12,663 11,291 12,302
Total Depreciation and Amortization (D&A)
0.00 0.00 112 114 0.00 123 120 116 241 226 238
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 12.72% 14.80% 16.70% 25.10% 18.98% 17.28%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 18.96% 21.12% 30.05% 27.29% 20.59% 18.32%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 16.05% 17.22% 21.75% 17.67% 13.17% 12.61%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.49 $1.57 $4.33 $1.50 $2.63 $0.84 ($0.02) $0.35
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 141.65M 139.63M 133.97M 134.40M 200.06M 193.36M 193.51M 194.02M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.48 $1.56 $4.27 $1.48 $2.61 $0.84 ($0.02) $0.35
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 141.65M 139.63M 133.97M 134.40M 200.06M 193.36M 193.51M 194.02M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 141.65M 139.63M 133.97M 134.40M 200.06M 193.36M 193.51M 194.02M
Normalized Net Operating Profit after Tax (NOPAT)
719 462 298 152 242 544 156 240 262 262 165
Normalized NOPAT Margin
4.78% 3.25% 2.22% 1.15% 1.88% 4.01% 1.34% 1.88% 1.18% 1.10% 0.75%
Pre Tax Income Margin
5.50% 3.54% 2.75% 0.78% 2.49% 5.39% 2.44% 3.87% 1.22% 0.36% 0.28%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.91 4.20 4.03 1.54 3.28 6.83 3.12 5.23 2.05 1.24 1.09
NOPAT to Interest Expense
5.57 3.48 2.76 1.24 1.91 4.81 1.50 2.26 1.30 1.77 1.60
EBIT Less CapEx to Interest Expense
0.00 0.00 1.84 -0.88 0.00 2.52 0.13 1.40 2.08 -1.22 -0.77
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.58 -1.18 0.00 0.50 -1.48 -1.57 1.32 -0.69 -0.26
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 31.82% 34.39% 27.14% 31.26% 54.45% 68.07%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 124.41% 95.79% 75.85% 106.71% 121.95% 68.07%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, investor‑focused read on Bunge Global SA (NYSE:BG) using the quarterly income statements, balance sheets, and cash flow statements provided for the last four years. The aim is to spot trends in revenue, margins, cash generation, and leverage that retailers may care about before considering a position in BG.

  • Revenue growth in 2025, led by a strong Q4: Q4 2025 operating revenue was 23.762B, up from 13.542B in Q4 2024, signaling meaningful top‑line expansion into the latest year.
  • Consistent quarterly operating profitability in 2025: Positive operating income across the 2025 quarters (Q4 2025: 374M; Q3 2025: 385M; Q2 2025: 320M; Q1 2025: 217M), indicating ongoing earnings power from core operations.
  • Solid cash from operations in late 2025: Net cash from continuing operating activities reached 1.347B in Q4 2025 and 0.854B in Q3 2025, highlighting improving liquidity generation in the second half of 2025.
  • Positive free cash flow in the latest quarter: In Q4 2025, free cash flow was roughly 231M (CFO about 1.347B minus capital expenditures of ~538M and investing outlays of ~578M), suggesting cash generation after sustaining capex and investments.
  • Strong near‑term liquidity in mid‑2025: Cash and cash equivalents stood around 6.8B in Q2 2025, providing a cushion to fund operations and capex without immediate external funding.
  • Significant, shareholder‑friendly earnings in 2025 across several quarters: For example, Q2 2025 shows basic earnings per share of about 2.63 and diluted 2.61, with net income attributable to common shareholders of about 354M, indicating material quarterly profitability.
  • Margins fluctuating but positive in 2025: Gross profit remains positive each quarter (Q4 2025: 1.011B on 23.762B revenue; Q3 2025: 1.063B on 22.155B; Q2 2025: 0.738B on 12.769B; Q1 2025: 0.597B on 11.643B), but gross margins have fluctuated and cooled versus some prior periods.
  • Working‑capital and cash flow volatility: CFO swings across quarters (positive in Q3‑Q4 2025, but negative in Q1–Q2 2025), suggesting quarterly working‑capital effects that complicate short‑term cash forecasting.
  • Leverage pressure from rising liabilities: As of Q3 2025, Total Liabilities were about 29.0B against Total Assets of roughly 46.3B and Total Equity of about 17.3B, implying substantial leverage that could raise interest costs and balance‑sheet risk.
  • Financing cash flows have been negative in several periods: Net cash from financing activities was notably negative in Q4 2025 (about −1.792B) and showed variability across 2025 quarters, reflecting debt repayments, dividends, and other financing outlays that can pressure liquidity if operating cash flow weakens.

Bottom line: BG delivered stronger top‑line growth in 2025 with positive operating profitability and solid mid‑year liquidity. Cash flow from operations strengthened in the back half of 2025, and free cash flow turned positive in Q4, underscoring improved liquidity. However, elevated leverage and cash‑flow volatility in some quarters warrant caution, and margin dynamics suggest continued monitoring of gross and operating margins as the business cycles. Retail investors should weigh BG’s growth opportunity against its debt load and cash‑flow variability when assessing downside risk or potential upside in this name.

05/07/26 01:44 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Bunge Global's Financials

When does Bunge Global's fiscal year end?

According to the most recent income statement we have on file, Bunge Global's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Bunge Global's net income changed over the last 3 years?

Bunge Global's net income appears to be on a downward trend, with a most recent value of $843 million in 2025, falling from $1.68 billion in 2022. The previous period was $1.19 billion in 2024. See Bunge Global's forecast for analyst expectations on what’s next for the company.

What is Bunge Global's operating income?
Bunge Global's total operating income in 2025 was $1.30 billion, based on the following breakdown:
  • Total Gross Profit: $3.41 billion
  • Total Operating Expenses: $2.11 billion
How has Bunge Global's revenue changed over the last 3 years?

Over the last 3 years, Bunge Global's total revenue changed from $67.23 billion in 2022 to $70.33 billion in 2025, a change of 4.6%.

How much debt does Bunge Global have?

Bunge Global's total liabilities were at $27.11 billion at the end of 2025, a 94.3% increase from 2024, and a 99.9% increase since 2023.

How much cash does Bunge Global have?

In the past 2 years, Bunge Global's cash and equivalents has ranged from $1.14 billion in 2025 to $3.31 billion in 2024, and is currently $1.14 billion as of their latest financial filing in 2025.

How has Bunge Global's book value per share changed over the last 3 years?

Over the last 3 years, Bunge Global's book value per share changed from 0.00 in 2022 to 82.25 in 2025, a change of 8,225.0%.



Financial statements for NYSE:BG last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners